Dr Avrum Bluming
๐ค SpeakerAppearances Over Time
Podcast Appearances
nor the London Times, is that when taken within 10 years of the last menstrual period, it actually decreases the risk of heart disease.
And that's what so many studies over the years long before 2002 have confirmed.
You mentioned osteoporosis.
Yes, a hip fracture from osteoporosis, which can affect a significant number of postmenopausal women, is associated with death within one year of the hip fracture that mirrors the incidence of death from breast cancer and the best treatment.
is estrogen, much better than calcium, which alone doesn't work in a postmenopausal women and the other drugs that are used for osteoporosis that when they work in prevention, work for five years, but after that are associated with an increased risk of hip fracture.
Estrogen, you can keep on using and it works as long as you use it.
And
Although they originally published in 2003 it has no effect on quality of life, they've now walked that back and said estrogen is the single best treatment for menopausal symptoms.
And they initially said that our findings apply to women of all ages.
And they've walked that back and now said, no, the bad findings really were for women who were long past menopause.
And now they said, we're so sorry that peri and menopausal women weren't started on estrogen.
That wasn't what our intention was.
Well, that's what you wrote, but you've walked it back.
Let's publicize that you've walked it back.
And
When challenged, the disagreement isn't there.
When people say, I don't know who to believe, these two people now who I'm listening to, or other people, well, we all agree.
It's just we're saying it out loud.
And let's talk about risk again for just a minute.
As you pointed out, the black box warning, which was put on all estrogen containing drugs, warned increases the risk of heart disease and breast cancer.